Crossmark

Prevalence of bleeding secondary to anticoagulation and mortality in patients with atrial fibrillation admitted with SARS-CoV-2 infection

Crossref DOI link: https://doi.org/10.1016/j.medcli.2021.06.015

Published Print: 2022-06

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Rubini-Costa, Ricardo

Bermúdez-Jiménez, Francisco http://orcid.org/0000-0003-0325-7349
Rivera-López, Ricardo

Sola-García, Elena http://orcid.org/0000-0002-7748-1194
Nagib-Raya, Hadi http://orcid.org/0000-0001-6084-3219
Moreno-Escobar, Eduardo http://orcid.org/0000-0002-1944-7668
López-Zúñiga, Miguel Ángel http://orcid.org/0000-0002-2583-316X
Briones-Través, Adela

Sanz-Herrera, Francisco

Sequí-Sabater, Jose Miguel http://orcid.org/0000-0001-8437-1623
Romero-Cabrera, Juan Luis http://orcid.org/0000-0001-6459-3536
Maíllo-Seco, Javier

Fernández-Vázquez, Felipe http://orcid.org/0000-0001-7187-1290
Rivadeneira-Ruiz, María

López-Valero, Lucas

Gómez-Navarro, Carlos http://orcid.org/0000-0002-6033-696X
Aparicio-Gómez, Jose Antonio

López, Miguel Álvarez

Tercedor, Luis

Molina-Jiménez, María

Macías-Ruiz, Rosa

Jiménez-Jáimez, Juan http://orcid.org/0000-0001-5541-898X
License Information

Text and Data Mining valid from 2022-06-01

stm-asf valid from 2022-06-01

stm-asf valid from 2022-06-01

stm-asf valid from 2022-06-01

stm-asf valid from 2022-06-01

stm-asf valid from 2022-06-01
More Information

This article is maintained by: Elsevier

Article Title: Prevalence of bleeding secondary to anticoagulation and mortality in patients with atrial fibrillation admitted with SARS-CoV-2 infection

Journal Title: Medicina Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcli.2021.06.015

Content Type: article

Copyright: © 2021 Elsevier España, S.L.U. All rights reserved.

Document is current

Any future updates will be listed below